ArticleBritish journal of haematology2014

Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.

Noriko Satake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.